Clinical Trials on Regional Transitional Cell Cancer of the Renal Pelvis and Ureter in Luxembourg
Total 0 results
Nothing found
Sponsors and Collaborators
- Etablissement Publique de Santé Mentale de la Réunion
- Incept BioSystems, Inc.
- ViiV Healthcare Australia Pty. Ltd
- Uzès hospital
- PharmTest s.r.o.
- MRC/UVRI & LSHTM Uganda Research Unit
- First Hospital Affiliated to Baotou Medical College, Baotou, China
- Institutos Nacionales de Salud, USA Instituto Alemán del Cáncer
- Vaxxinity, Inc.
- Medtronic Poland Spółka z ograniczoną odpowiedzialnością
- Marta Camats Terre
- CK-CARE (Christine Kühne - Center for Allergy Research and Education)
- Pyrotech Therapeutics, Inc.
- Diabetech
- Centre de Pharmacologie Clinique, INSERM CIC 501
- Ministry of Tourism, Sport and the Arts, British Columbia
- Jadran Galenski laboratorij d.d.Rijeka
- St. Louis Children's Hospital
- Tianjin Medical University
- Medical School University of Zagreb
- View Full List
Medical Conditions
- Vomit
- Family Functioning
- Neoplasms, Advanced Solid
- Human Papilloma Virus Infection
- Vasomotor Symptoms Associated With Menopause
- Relapsed Malignant Solid Tumor
- Breast Cancer Treatment
- Native and Valve in Valve Aortic Valve Failure
- High Turnover Bone Disease
- Hepatitis C, Treatment Naïve, Genotype 1 Patients
- Repository Corticotropin Injection
- Pulpotomy of Young Permanent Molars
- Fenofibrate
- Non-sedentary
- Nonarthritic Hip Disease
- Well-trained Athletes
- Post-Cerebrovascular Accident (CVA) Hemiparesis
- Oral Allergic Syndrome
- Central Centrifugal Cicatricial Alopecia (CCCA)
- Critical Illness Sepsis, Severe
- View Full List
Drug Interventions
- Corticosteroid with local anaesthetics (40 mg of triamcinolone acetonide (40 mg/ml) with 1.5 ml mepivacaine HCl 3% )
- Poziotinib Twice Daily Dosing
- Midazolam
- MCBC regimen
- Brexpiprazole
- Androgen Deprivation Therapy
- Rilpivirine
- Sulphonylurea
- Itraconazole
- Sildenafil 2%
- Deferoxamine (DFO)
- Transdermal estradiol
- QL2109
- Glimepiride
- Anlotinib
- Gilteritinib
- ACE-536
- AG-024322
- Pembrolizumab
- Isotonic solution (NaCl 0.9%)
- View Full List
CROs by country
- Contract Research Organizations in Argentina
- Contract Research Organizations in Australia
- Contract Research Organizations in Azerbaijan
- Contract Research Organizations in Belarus
- Contract Research Organizations in Guatemala
- Contract Research Organizations in India
- Contract Research Organizations in Lebanon
- Contract Research Organizations in Mali
- Contract Research Organizations in Philippines
- Contract Research Organizations in Serbia
- Contract Research Organizations in Slovenia
- Contract Research Organizations in Türkiye
- Contract Research Organizations in Ukraine
- CRO list by country